Viviane Montarnal
General Counsel bei QUOTIENT LIMITED
Profil
Viviane Montarnal is currently the Head-Legal Affairs & Compliance at Quotient Ltd.
Prior to this, he worked as the Vice President & Associate General Counsel at Haemonetics Corp.
from 2015 to 2020.
He also worked as a Senior In-House Counsel at Integra LifeSciences Holdings Corp.
and Ipsen SA. Montarnal has a graduate degree from the University of Orsay and Université Paris Nanterre, and an undergraduate degree from the Institute of Intercultural Management & Communication.
He also has a graduate degree from Université Paris-Saclay.
Aktive Positionen von Viviane Montarnal
| Unternehmen | Position | Beginn |
|---|---|---|
| QUOTIENT LIMITED | General Counsel | 01.04.2020 |
Ehemalige bekannte Positionen von Viviane Montarnal
| Unternehmen | Position | Ende |
|---|---|---|
| HAEMONETICS CORPORATION | Corporate Officer/Principal | 01.03.2020 |
| IPSEN | Corporate Officer/Principal | - |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Viviane Montarnal
| University of Orsay | Graduate Degree |
| Université Paris Nanterre | Graduate Degree |
| Université Paris-Saclay | Graduate Degree |
| Institute of Intercultural Management & Communication | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| HAEMONETICS CORPORATION | Health Technology |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Health Technology |
| IPSEN | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Quotient Ltd.
 Quotient Ltd. Electronic Equipment/InstrumentsElectronic Technology Quotient Ltd. is a commercial-stage diagnostics company, which provides immunohematology products to hospitals and blood banks. Its products and services include MOSAIQ and ALBA. The firm develops, manufactures, and sells conventional reagent products to equipment manufacturers. It engages in transfusion diagnostics, which focuses on blood grouping and serological disease screening. The company was founded on January 18, 2012 and is headquartered in Eysins, Switzerland. | Electronic Technology |
